• AZD1480: Practical JAK2 Inhibitor Workflows

  2026-08-17

  AZD1480 provides a direct way to interrogate tumor-intrinsic JAK2/STAT3 signaling, including adaptive IL-6-driven survival responses that may be missed by immune-focused assays. This guide connects dose-response design, phosphoprotein validation, myeloma models, and tumor–immune co-culture workflows with practical troubleshooting.

• JNJ-26481585 (Quisinostat) in Cancer Research

  2026-08-17

  JNJ-26481585, also called Quisinostat, is a potent epigenetic modulator that preferentially inhibits class I HDAC enzymes. Preclinical evidence links its HDAC activity to histone H3 hyperacetylation, apoptosis, tumor growth inhibition, and reduced TRIM21-associated resistance in pituitary adenoma models.

• Pazopanib Hydrochloride Cancer Assay Workflows

  2026-08-16

  Build more informative oncology assays with Pazopanib Hydrochloride (GW786034), a multi-target inhibitor suited to tumor-growth and angiogenesis models. This guide separates growth arrest from cell killing, improves dose-response design, and provides practical troubleshooting for renal cell carcinoma and soft tissue sarcoma research.

• Hoechst 33258 Workflows for Tumor Cell Assays

  2026-08-15

  Hoechst 33258 provides a practical nuclear readout for microscopy, cell counting, and DNA-content analysis in tumor models exposed to pH-disrupting therapies. This guide connects live-cell and fixed-cell staining with lactate, pH, uptake, and chemo-immunotherapy workflows while separating DNA visualization from direct pH measurement.

• Deferiprone: Iron Stress as a Translational Lever

  2026-08-14

  Deferiprone offers translational researchers a controllable way to interrogate how iron availability reshapes metabolism, proliferation, oxidative stress, and cell fate. By connecting enterocyte metabolomics with cancer, cardiac, and neurovascular models, this article positions 3-hydroxy-1,2-dimethylpyridin-4-one as a strategic tool for mechanism-driven research rather than a simple chelation reagent.

• Alternariol and LX-2 Cells in Liver Fibrosis

  2026-08-14

  The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can activate LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast phenotype, whereas tenuazonic acid showed no significant effect in the tested model. By combining lncRNA–mRNA omics with pathway analysis and a CotA laccase detoxification strategy, the work connects Alternaria toxin exposure with fibrotic signaling and provides a framework for mechanistic mycotoxin research.

• Cefoperazone Sodium Salt Assay Workflows

  2026-08-13

  Build reproducible antibacterial assays, resistance studies, and tissue-relevant infection models with Cefoperazone sodium salt. This guide combines evidence-based assay design with practical formulation, MIC/MBC interpretation, and troubleshooting strategies.

• Brain-to-Spinal Control of Opioid Pain Hypersensitivity

  2026-08-13

  The 2024 Neuron study identifies a lateral parabrachial nucleus–hypothalamus–spinal dorsal horn pathway that regulates morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Its findings distinguish central control of mechanical pain from established mechanisms of thermal opioid responses and provide a circuit-level framework for studying opioid-related pain abnormalities.

• Midecamycin: An Assay-First Research Guide

  2026-08-12

  Midecamycin is an acetoxy-substituted macrolide antibiotic whose ribosome-level activity requires careful interpretation across species and assay formats. This guide connects MIC testing, glycosylation controls, and exposure–response thinking to improve antibacterial research decisions.

• Pexmetinib (ARRY-614) Cytokine Assay Workflows

  2026-08-12

  Build more informative inflammation assays with Pexmetinib (ARRY-614), a dual p38 MAPK and Tie2/Tek inhibitor suited to cytokine, bone-marrow, and signaling studies. This guide connects dose-response design with phospho-kinase kinetics, matrix controls, and practical troubleshooting.

• Imatinib (STI571) for CML Kinase and NET Research

  2026-08-11

  Imatinib (STI571) provides a practical way to separate BCR-ABL, PDGF receptor, and c-Kit signaling from downstream effects on proliferation and neutrophil extracellular trap formation. This guide translates kinase inhibition into reproducible CML workflows, comparative NET assays, and troubleshooting decisions for signal transduction and cancer biology research.

• Protease Inhibitor Cocktail: EDTA-Free 200X in DMSO

  2026-08-11

  This EDTA-free Protease Inhibitor Cocktail helps limit proteolytic loss during cell lysis, protein extraction, and protease-sensitive assays while avoiding intentional chelation of divalent cations. It is suitable for workflows such as Western blotting, co-immunoprecipitation, kinase assays, and pull-downs, but its concentration, DMSO contribution, and possible assay interference should be validated for each sample type.

• DFO for Porous-Substrate Fingerprint Detection

  2026-08-10

  DFO (9H-1,8-Diazafluoren-9-one) is a practical fluorescent reagent for revealing amino-acid-rich latent prints on paper and other porous evidence. This guide connects substrate handling, solution preparation, imaging controls, and troubleshooting with a modern evidence-based approach to assay reproducibility.

• Pulmonary Arterial Remodeling and RV Afterload

  2026-08-09

  The reference study uses a subject-specific one-dimensional fluid–structure interaction model to separate how distal vascular resistance and arterial compliance shape pulmonary hypertension hemodynamics. Its central finding is that increased distal resistance most strongly raises maximum main pulmonary artery pressure, whereas reduced compliance substantially increases characteristic impedance, providing a quantitative framework for interpreting right ventricular afterload.

• Crizotinib Hydrochloride in Tumor Assembloids

  2026-08-08

  Crizotinib hydrochloride extends patient-derived gastric cancer assembloids from descriptive models into mechanism-focused drug-response assays. By comparing matched organoids with stromal co-cultures, researchers can distinguish target-pathway inhibition from microenvironment-driven resistance.

541 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page